The 113th Abbott Nutrition Research Conference
A Ramachandran, MD, PhD, DSc, FRCP, Dr A. Ramachandran’s Diabetes Hospitals, India
Prevalence of type 2 diabetes is increasing globally, but the change is very significant in developing countries such as India, which has 61.3 million people affected by the disease. Dr Ramachandran states that Indians have a high ethnic and genetic susceptibility to diabetes, as well as lower threshold limits for environmental risk factors. It is a matter of major concern that Indians develop type 2 diabetes at a younger age than Western populations. Thus, diabetes presents a serious economic burden to both the nation and individuals within it. Dr Ramachandran argues that creating general awareness about diabetes and complications is the primary step in the crusade against the disease, and that research should continue to seek feasible and practical tools for primary prevention of diabetes.